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Background: Oxytocin has been reported for a wide range of adverse effects in different species of lactating
animals. The present study was aimed to evaluate the adverse effects of oxytocin on biomarkers of oxidative stress
in buffaloes. Lactating buffaloes (n = 40) were randomly selected from a commercial dairy farm located in the
peri-urban area of district Faisalabad, Pakistan and divided into two equal groups viz. treatment and control groups,
each containing 20 buffaloes. Buffaloes in treatment group were injected with oxytocin before each milking
(morning and evening) for milk let down; whereas, animals in control group were milked naturally without oxytocin
injection. Both the groups were assessed for oxidative stress biomarkers.
Results: Results showed significantly higher levels (P ≤ 0.05) of TOS, tHcy and ceruloplasmin oxidase activity in
lactating buffaloes injected with oxytocin as compared to those of control group. On the other hand, serum levels
of TAS, PON1 and arylesterase were significantly lower (P ≤ 0.05) in the buffaloes of treatment group.
Conclusions: Oxytocin injection in lactating buffaloes resulted in elevated oxidative stress by increasing the total
homocysteine and ceruloplasmin oxidase activity and decreasing enzymatic activities of antioxidant enzymes including
paraoxonase-1 and arylesterase; that might render the animals to poor productive and reproductive potential.
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Buffaloes are said to be slow and hard milkers because
of their slow milk ejection reflexes and hard teat sphinc-
ter muscles [1]. As a general practice, exogenous oxyto-
cin injections are frequently administered in dairy
animals to initiate the milk let down or occasionally to
cure the disturbed milk ejection [2,3]. However, long
term oxytocin administration in dairy animals could lead
to addiction and reduced spontaneous milk ejection after
withdrawal of oxytocin [4].
Total antioxidant capacity (TAC) provides biologically
more relevant information that describes the dynamic equi-
librium between pro-oxidants and antioxidants in the
plasma compartment of animals and human beings [5].
Under physiological conditions, there are sufficient reserves
of antioxidants in the body that has the capability to cope
with the production of free radicals [6], which are produced
continuously during normal metabolism and may increase* Correspondence: drziar@yahoo.com
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reproduction in any medium, provided the oras a result of pathological conditions [7]. However, when
the production of free radicals exceeds the body’s antioxi-
dant production potential, oxidative stress develops [8]. In
dairy animals, pre-partum and early post-partum periods
are very critical as they prone the animals to considerable
physiological challenges by imposing significant metabolic
stressors that may contribute to the onset of diverse disor-
ders including ketosis, milk fever, mineral deficiencies etc.
[9]. In Pakistan, oxytocin is widely used in dairy animals to
increase the milk production due to the lack of awareness
about the health hazards associated with irrational use of
oxytocin. Keeping in view, the present study was conducted
to determine the effect of oxytocin injection on health/oxi-
dative stress biomarkers of lactating buffaloes.
Results
Indicators of oxidative stress
Total oxidant status (TOS) and total antioxidant capacity (TAC)
In oxytocin injected group, the serum TOS (μMol/L)
was significantly higher (P ≤ 0.05) during 1st (0.97) and
5th month (0.98) of lactation as compared to control groupd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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cantly higher (P ≤ 0.05) in control buffaloes on 2nd (0.40),
3rd (1.06), 4th (0.78) and 6th months (0.55) of lactation as
compared to oxytocin injected buffaloes; whereas, the
highest value for TAC was recorded on 3rd month (1.06) of
lactation in control group (Table 1). Pearson correlation co-
efficients indicated that TOS was positively correlated (r =
0.604) with TAC in the control buffaloes (Table 2); whereas,
in treated buffaloes no such significance was detected.
Total homocysteine (tHcy)
A significantly higher (P ≤ 0.05) concentration of tHcy
(μMol/L) was recorded in buffaloes of oxytocin injected
group on 1st (16.77), 2nd (17.04) and 4th months
(17.52) of lactation when compared with those of control
group; whereas, highest tHcy concentration was detected
on 4th month (17.52) of lactation (Table 1). Correlation
analysis revealed a positive correlation of tHcy with TOS
(r = 0.481) and TAC (r = 0.389; Table 2).
Paraoxonase-1 (PON1) activity
Buffaloes of control group showed significantly higher
(P ≤ 0.05) serum PON1 activity (U/L) during 2nd (58.29),
4th (51.41) and 5th months (46.98) of lactation as com-
pared to those of oxytocin injected group which showed
significantly higher PON1 activity during 1st month
(45.74) of lactation (Table 1). PON1 activity of control
group was positively correlated with TOS (r = 0.211), TAC
(r = 0.209), ceruloplasmin oxidase activity (r = 0.184) and
negatively correlated with arylesterase activity (r = –0.379;
Table 2). PON1 activity of the lactating buffaloes injected
with oxytocin showed a negative correlation with cerulo-
plasmin oxidase activity (r = −0.255).
Arylesterase activity
The serum arylesterase activity (U/L) increased signifi-
cantly (P ≤ 0.05) during 1st (47.12), 5th (40.74) and 6th
months (52.06) of lactation and the highest level was ob-
served during 6th month (52.06) in the control group
(Table 1). Arylesterase activity of oxytocin injected group
was positively correlated with TAC (r = 0.324) and ceru-
loplasmin oxidase activity (r = 0.199).
Ceruloplasmin oxidase activity
Animals injected with oxytocin showed significantly higher
(P ≤ 0.05) ceruloplasmin oxidase activity (U/L) during 1st
(55.91) and 4th months (100.44) of lactation as compared
to control group; whereas, on 3rd month of lactation the
difference between the ceruloplasmin oxidase activity of
both the groups was statistically similar (P ≥ 0.05) (Table 1).
Discussion
Oxytocin has been reported for a wide range of adverse
effects in lactating animals including sheep, goat, cattleand buffaloes [2-4]. In lactating animals, the start of lac-
tation is an important event with respect to the produc-
tion of free radical(s). It has been reported in the
literature that in malnourished lactating animals, nega-
tive energy balance is developed and in such circum-
stances, oxytocin favors the production of free radicals
through mobilization of stored lipids and gluconeogene-
sis [10,11]. Further, excessive oxidation of non-esterified
fatty acids (NEFA) in the liver also increased the produc-
tion of reactive oxygen species (ROS) which ultimately
produced the oxidative stress [12].
In the present study, statistically TOS was higher and
TAC was lower in oxytocin injected buffaloes and these
results are consistent to the findings of [6] who
conducted similar studies in lactating cows. This might
be due to the depletion of fat soluble antioxidants by the
milk [8,13]. Further, this reduction might also be due to
decreased level of PON1 [14] that was another peculiar
finding of this study. Moreover, in some previous stud-
ies, reduction in TAC just after calving had also been
correlated with increased production of reactive oxygen
metabolites (ROM) and thiobarbituric acid reactive sub-
stance. Elevation in these reactive substances induced
imbalance between TAC and production of free radicals
leading to lipid peroxidation [15].
Oxidative stress has an important role in the metabol-
ism of homocysteine. In present study, significantly
higher tHcy level was detected in oxytocin injected buf-
faloes that might be correlated with higher level of free
radicals in circulation [16]. Similarly, [10] also observed
a significant increase in the serum homocysteine on day
200 of lactation in the lactating ewes. Altered plasma
homocysteine levels had also been correlated with cer-
tain dietary factors such as protein and vitamin deficien-
cies [16,17], renal dysfunction and hypothyroidism [18].
The results of enzymatic activities revealed significantly
lower PON1 and arylesterase levels in oxytocin injected
buffaloes as compared to control [14,19-21] also found a
lower PON1 activity in the pregnant, early lactating and
late lactating dairy cows. It might be correlated with in-
creased level of homocysteine that triggered the athero-
sclerosis process due to which expression of PON1 gene
in the hepatic tissue was down regulated [22,23]. It could
be speculated that proatherogenic effects of tHcy might be
involved in the reduction of serum PON1 activity and thus
altered antioxidant function. The PON1 enzyme is respon-
sible for both paraoxonase and arylesterase activities in
bovine serum, because it hydrolyses organophosphates
(such as paraoxon) and aromatic esters such as phenyl
acetate [24,25]. Moreover, the elevated oxidative stress in
the form of free radicals in the present study could lower
PON1 activity [14,19]; whereas, increased lipid metabol-
ism in the form of lipid peroxidation might also result in
lower PON1 activity [21]. The lipids act as substrate for
Table 1 Oxidative stress parameters (Mean ± SE) of control and treated (oxytocin injected) lactating Bubalis bubalis (Nili Ravi) during different months of
lactation
Parameters 1st month 2nd month 3rd month 4th month 5th month 6th month
C T C T C T C T C T C T
TOS (μMol/L) 0.47 ± 0.02c 0.97 ± 0.08ab 0.79 ± 0.09b 0.79 ± 0.09b 1.10 ± 0.07a 1.12 ± 0.08a 1.08 ± 0.06a 1.00 ± 0.05ab 0.36 ± 0.03c 0.98 ± 0.071ab 0.78 ± 0.09b 0.97 ± 0.06ab
TAC (mMol/L) 0.30 ± 0.01efg 0.20 ± 0.02fg 0.40 ± 0.06de 0.26 ± 0.02fg 1.06 ± 0.02a 0.49 ± 0.06cd 0.78 ± 0.03b 0.32 ± 0.02ef 0.18 ± 0.02g 0.28 ± 0.02efg 0.55 ± 0.08c 0.25 ± 0.01fg
tHcy (μMol/L) 12.72 ± 0.59cd 16.77 ± 0.99a 10.43 ± 0.30d 17.04 ± 0.84a 14.20 ± 0.65bc 15.77 ± 0.66ab 12.15 ± 0.86cd 17.52 ± 0.57a 14.03 ± 0.92bc 16.52 ± 0.56ab 15.32 ± 0.33ab 17.44 ± 0.52a
PON1 activity (U/L) 35.06 ± 2.68g 45.74 ± 2.63bcd 58.29 ± 2.41a 48.71 ± 1.92bc 50.41 ± 1.63bc 45.59 ± 2.22bcde 51.41 ± 2.66ab 40.59 ± 1.33defg 46.98 ± 1.12bcd 38.51 ± 1.46efg 43.75 ± 1.23cdef 37.64 ± 0.86fg
Arylesterase activity (U/L) 47.12 ± 1.45ab 32.94 ± 1.04f 32.98 ± 1.38ef 28.09 ± 1.40f 43.94 ± 1.59bc 45.08 ± 1.75bc 38.29 ± 0.80de 43.44 ± 2.11bcd 40.74 ± 1.35cd 30.16 ± 1.35f 52.06 ± 0.74a 32.86 ± 1.77f
Ceruloplasmin oxidase
activity (U/L)
32.06 ± 2.35e 55.91 ± 5.71bcd 45.31 ± 2.87de 33.09 ± 1.82e 51.63 ± 2.09cd 50.73 ± 3.80d 56.17 ± 4.07bcd 100.44 ± 5.54a 69.94 ± 4.59b 65.20 ± 4.55bc 65.31 ± 4.68bc 58.16 ± 1.74bcd
Values with different alphabets in a row significantly differ at (P ≤ 0.05).
Standard abbreviations and units are given in parenthesis.
“C” = Control group; “T” = Treatment group (oxytocin injected).
“TOS” = Total oxidant status; “TAC” = Total antioxidant capacity.

















Table 2 Correlation coefficients of oxidative stress parameters in control lactating (Nili Ravi) buffaloes
Parameters Total oxidant status Total antioxidant capacity Arylesterase activity Ceruloplasmin oxidase activity
Total oxidant status (μMol/L) 0.604
(0.000)
Total homocysteine (μMol/L) 0.481 0.389
(0.000) (0.002)
Paraoxonase 1 activity (U/L) 0.211 0.209 −0.379 0.184
(0.020) (0.022) (0.000) (0.044)
Values in parenthesis indicate significance (P ≤ 0.05).
Standard abbreviations and units are given in parenthesis.
Blank cells indicate non-significant correlation at P ≥ 0.05.
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tween lipid peroxidation and PON1 activity [26]. Add-
itionally, inflammatory conditions induced by oxytocin
injection could also be responsible for elevated oxidative
stress, which directly decreased the PON1 activity [27].
Ceruloplasmin oxidase activity was found significantly
higher in oxytocin injected buffaloes as compared to
control. Ceruloplasmin has oxidase activity and is related
with the host acute phase responses [28] and antioxidant
defense in cattle [29,30] so, its level might be enhanced
during inflammation, tissue insult, certain malignant
tumors [31,32] and oxidative stress to quench the free
radicals, produced during oxidative stress. So, cerulo-
plasmin oxidase activity is the important health param-
eter that could be used to judge the health status and
well-being of the animals [33]. Previous studies reported
that higher ceruloplasmin oxidase activity in freshly
calved animals is linked with a physiological phenome-
non [34-36]. In the present study, increased activity of
ceruloplasmin might be due to pathological inflamma-
tory condition, induced by oxytocin [27]. In inflamma-
tory conditions, cytokines such as interleukin-1 and
interleukin-6 are released from leukocytes which stimu-
late the liver to secrete ceruloplasmin [37].
Conclusions
In conclusion, oxytocin injection in lactating animals
resulted in higher oxidative stress by enhancing the total
homocysteine level and ceruloplasmin oxidase activity
and decreasing enzymatic activities of antioxidant en-
zymes including paraoxonase-1 and arylesterase. The re-
sults of present study discourage the irrational use of
oxytocin for milk let down in lactating animals that may




Healthy, 4-7 years old freshly calved lactating (Nili Ravi)
buffaloes (n = 40) were randomly selected and main-
tained on a commercial dairy farm located in the peri-urban area of district Faisalabad, Pakistan. The animals
were allocated into two equal groups (n = 20, each) viz.
treatment (oxytocin injected) and control (without oxy-
tocin injection) groups.
Both the groups were assigned to 4 replicates, 5 ani-
mals each. All the animals were milked twice a day
(4.00 am and 4.00 pm), by injecting 3 ml of oxytocin
(10 IU/mL; Star Laboratories, Pakistan) 3–5 minutes be-
fore each milking.
Blood sampling was started exactly from day 15th post
delivery that continued for a period of six months with
an interval of 15 days between two successive samplings.
Blood samples were collected from jugular vein using
BD-vacutainer and sera samples were separated in
eppendorf tubes from collected blood samples at 1107×g
for 15 minutes and stored at −20°C till analysis. All ani-
mal care and experimental procedures were carried out
in accordance with the guide for the humane use and
care of animals, approved by the animal care committee
of University of Agriculture-Faisalabad, Pakistan.
Determination of oxidative stress
Measurement of total oxidant status (TOS)
The TOS of the body was estimated using the method, de-
veloped by [38]. Briefly, 35 μl of serum samples were
mixed with 225 μL of reagent 1 (150 μM xylenol orange,
140 mM NaCl and 1.35 M glycerol having a total volume
of 1000 ml; pH, 1.75). After mixing, the first absorbance
was read. Then, 11 μL of reagent 2 (5 mM ferrous ammo-
nium sulfate and 10 mM O-dianisidine dihydrochloride)
was mixed with the solution containing reagent 1 and the
serum sample. The final absorbance was read after 4 mi-
nutes after mixing with reagent 2 at bichromatic wave-
lengths, using a main wavelength of 560 nm and
secondary/differential wavelength of 800 nm. Then the
TOS concentrations were calculated in terms of micromo-
lar per liter of hydrogen peroxide.
Measurement of total antioxidant capacity (TAC)
The total antioxidant capacity of the body was deter-
mined by using a novel automated ABTS radical cation
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with 200 μl of reagent 1 (0.4 M/L sodium acetate and
0.4 M/L glacial acetic acid; pH 5.8). Then 20 μl of reagent
2 (30 mM/L acetate buffer solution, 2 mM/L H2O2 and
10 mM/L 2,2′-azinobis 3-ethylbenzothiazoline-6-sulfon-
ate; ABTS) was added to this mixture and reading was
taken after 5 minutes of incubation at 37°C. This absorb-
ance was used to determine the TAC in terms of milimolar
per liter of Trolox (Sigma, Vit. E analogue).
Total homocysteine
The quantitative determination of total L-homocysteine
in the serum was determined by using the commercially
available kit (The Diazyme Homocysteine Enzymatic
Assay Kit; Ref. # DZ 568A-K; Diazyme Laboratories,
Gregg Court Poway, CA 92,064, USA).
Determination of enzymatic activities
Paraoxonase-1(PON1) activity
The PON1 activity was determined by the hydrolysis of
paraoxone into p-nitrophenol as described by [40].
Briefly, 10 μL of serum sample was mixed with 350 μL
of paraoxonase substrate reagent 0.1 M Tris–HCl buffer
of pH 8.0, 2 mM paraoxone (Sigma-Aldrich Laborchemi
Kalien GmbHD-30,918, Seelze, Germany) as substrate
and 2 mM CaCl2 without NaCl stimulation. The gener-
ation of p-nitrophenol was monitored at 405 nm on
spectrophotometer Biosystem, BTS-330 (Biosystems, S.
A. Costa Brava, Barcelona, Spain). The PON1 activity in
terms of international units (U/L) was calculated by
using the formula; [PON1 activity(U/L) = (Absorbance/
0.017) × 50]
Wheres, 50 = dilution factor
0.017 =Micromolar absorptivity of the p-nitrophenol.
Arylesterase activity
Arylesterase activity was measured in term of
phenylacetate hydrolysis as described by [41]. The reac-
tion mixture contained 350 μL of arylesterase substrate
(2.0 mM phenylacetate, 2 mM CaCl2 in 0.1 M Tris–HCl
buffer of pH 8.0) and 10 μL of serum. The initial rate of
hydrolysis was determined following the increase in
arylesterase activity at 270 nm (Biosystem, BTS-330).
The enzyme activity (U/L) was calculated by using the
same formula as mentioned for PON1 Activity.
Ceruloplasmin oxidase activity
The enzymatic activity of ceruloplasmin oxidase was
measured by using the slightly modified colorimetric
method of [42]. Briefly, 750 μl of acetate buffer (pH 5)
was mixed with 50 μl of the serum sample and incu-
bated at 30°C (water bath) in duplicate test tubes for
5 minutes. Then 200 μl of substrate (250 mg of ortho-
dianisidine dihydrochloride (Sigma) was brought upto100 ml with deionized water), was added to both the test
tubes. After 5 and 15 minutes of substrate addition, 2 ml
of sulfuric acid (9 M) was added to stop the reaction.
The absorbance of both the test tubes was taken at
540 nm wavelength by using a UV/Vis spectrophotom-
eter (Hitachi U-2001, USA). Then following formula was
used to calculate the enzymatic activity.
Ceruloplasmin oxidase activity U=Lð Þ ¼ Abs15min‐Abs5min  6:25  102
Whereas,
Abs15min and Abs5min were the absorbance of samples
after 15 and 5 minutes respectively. 6.25 × 102 was the
dilution factor of the reaction mixture.
Statistical analysis
Data were analyzed statistically using two way analysis of
variance, whereas, the means for significance between
different groups was detected by using Duncan Multiple
Range Test (DMR). All the values were considered sig-
nificant at P ≤ 0.05.
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